Detalhe da pesquisa
1.
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer.
Cell
; 184(12): 3143-3162.e32, 2021 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34004147
2.
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.
Mol Cell
; 81(10): 2183-2200.e13, 2021 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34019788
3.
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma.
Proc Natl Acad Sci U S A
; 120(36): e2306414120, 2023 09 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37643213
4.
New standards of care for treatment of diffuse large B-cell lymphoma.
Br J Haematol
; 204(4): 1132-1134, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38251726
5.
Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study.
Br J Haematol
; 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38485116
6.
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.
Intern Med J
; 54(2): 328-336, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38146232
7.
UK Biobank: a globally important resource for cancer research.
Br J Cancer
; 128(4): 519-527, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36402876
8.
The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance.
Br J Haematol
; 201(5): 887-896, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36880558
9.
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas.
Blood
; 137(21): 2947-2957, 2021 05 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33259592
10.
Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
Intern Med J
; 52(12): 2172-2175, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36436197
11.
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
Intern Med J
; 52(9): 1624-1632, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34927329
12.
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience.
Intern Med J
; 51(11): 1825-1834, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32609419
13.
COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
Intern Med J
; 51(5): 763-768, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34047035
14.
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.
Intern Med J
; 50(6): 667-679, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32415723
15.
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance.
Br J Haematol
; 187(2): 174-184, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31236941
16.
Two cases of refractory IgG4-related disease successfully treated with tocilizumab.
Ann Hematol
; 101(7): 1593-1594, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35152313
17.
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre.
Intern Med J
; 52(7): 1286-1287, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35879233
18.
Disseminated Lomentospora prolificans infection in a patient on idelalisib-rituximab therapy for relapsed chronic lymphocytic leukaemia.
Ann Hematol
; 99(10): 2455-2456, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32451706
19.
Prevention and management of obinutuzumab-associated toxicities: Australian experience.
Int J Nurs Pract
; 21 Suppl 3: 15-27, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26681665
20.
Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma.
Curr Opin Hematol
; 21(4): 297-308, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24811162